- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2008
- Public Summary Document (PSD) November 2008 PBAC Meeting - PDF
Oseltamivir – November 2008
Oseltamivir, capsules 30 mg, 45 mg and 75 mg, powder for oral suspension, 12 mg per mL, Tamiflu®, November 2008
Last updated
19 March 2009